Skip to main content
Rebecca Shatsky, MD, Oncology, La Jolla, CA

Rebecca Arielle Shatsky MD

Oncology•La Jolla, CA

Breast Cancer

Associate Professor of Clinical Medicine, Scientific Director Inflammatory and Triple-Negative Breast Cancer Program, UC San Diego Breast Medical Oncology Team Leader, National Clinical Operations Co-Chair for the I-SPY 2.2 Trial

Join to View Full Profile

  • 9400 Campus Point Dr, 3rd Floor #7329La Jolla, CA 92037

  • Phone+1 858-249-3230

  • Fax+1 858-822-6136

Dr. Shatsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Shatsky's Full ProfileAlready have an account?

Summary

  • Breast Cancer Medical Oncologist specializing in the treatment of young patients, triple negative breast cancer, lobular breast cancer and advanced/metastatic disease. Associate Professor of Medicine at UC San Diego. Breast Medical Oncology Co-Team Leader.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2011 - 2014
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 2011, MD
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology
  • Cornell University
    Cornell UniversityBA

Certifications & Licensure

  • CA State Medical License
    CA State Medical License Active through 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Doctor San Diego Medical Society, 2024
  • San Diego Top Doctor 2023
  • San Diego Top Doctor San Diego Medical Society, 2022
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial  
    Shatsky, R et. al, Nature Medicine, 9/14/2024
  • Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial  
    Parker BA, Shatsky RA, Schwab RB, Wallace AM; I-SPY 2 Consortium; Wolf DM, Hirst GL, Brown-Swigart L, Esserman LJ, van 't Veer LJ, Ghia EM, Yau C, Kipps TJ., Breast Cancer Research and Treatment, 4/8/2023

Press Mentions

  • Systemic Therapy in Breast Cancer
    Systemic Therapy in Breast CancerJune 1st, 2024
  • In Denial: When Patients Don’t Want to Believe They Have Cancer
    In Denial: When Patients Don’t Want to Believe They Have CancerAugust 26th, 2022
  • Oncternal Therapeutics Presents Clinical Data on Cirmtuzumab at SABCS 2019
    Oncternal Therapeutics Presents Clinical Data on Cirmtuzumab at SABCS 2019December 12th, 2019
  • Join now to see all

Grant Support

  • Integrated Machine-Learning Platform to Inform Precision Therapy in Underrepresented Triple-Negative Breast Cancer PatientsCalifornia Institute for the Advancement of Precision Medicine2019–2021
  • A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breastPadres Pedal the Cause2019–2021

Professional Memberships

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Rebecca Shatsky, Dr. Rebecca Shatsky, MD, Dr. R Shatsky, Dr. Rebecca Arielle Shatsky